Resuscitation Strategies in Septic Shock (ReSSeS)
Septic Shock, Critically Ill
About this trial
This is an interventional treatment trial for Septic Shock focused on measuring Septic shock, Critically ill patients, Transpulmonary thermodilution, Fluid resuscitation
Eligibility Criteria
Inclusion Criteria:
- Age > 18 years
- Clinical evidence of sepsis (microbiology confirmation, radiological or direct view (pus in biological fluid) or direct surgical view).
≥ 2 SIRS criteria:
- Temperature < 36.0°C or > 38.0°C
- Heart rate > 90 bpm
- Respiratory rate > 20 rpm or PaCO2 < 4.2 kPa or need of mechanical ventilation.
- Leukocytes > 12.0 x109/L or < 4.0 x109/L or >10% bands
- Circulatory shock defined as sustained systemic hypotension (systolic arterial pressure <90 mmHg or MAP <65 mmHg (<75 mmHg in a hypertensive patient) despite a 1,000 ml IV fluid challenge over 30 min (including IV fluids administered pre-ICU) or the need for vasopressor therapy. Hypertensive patients are patients with a history of confirmed hypertension treated with antihypertensive agents.
- Mechanical ventilation by endotracheal tube (any form)
Exclusion Criteria:
- Pregnancy
- Pre-terminal illness with life expectancy <28 days
- Duration of circulatory shock >6 hours
- Severe peripheral arterial vascular occlusion disease (Fontaine level III-IV)
- Inability for femoral artery canulation
- No informed consent
Sites / Locations
- Medisch Spectrum TwenteRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Transpulmonary thermodilution (TPTD)
Surviving Sepsis Guidelines (SSG)
The intervention group (TPTD guided therapy) follows a fluid resuscitation protocol based on stroke volume variation (SVV) and extravascular lung water (EVLW). Initial trigger for fluid loading when circulatory insufficiency is present will be SVV.
The standard group (SSG guided therapy) follows a fluid resuscitation protocol based on the Surviving Sepsis Campaign recommendations. Initial trigger for fluid loading when circulatory insufficiency is present will be the CVP (target ≥12 mmHg).